Integrated solutions based on the science of imaging biomarkers
780+
Clinical trials231,000
Subjects50,500
SitesMedical imaging endpoints can provide objective evidence of a drug’s safety and efficacy across all phases of development. ICON provides end-to-end integrated solutions based on the science of imaging biomarkers via cutting edge technology and image analysis tools. Our use of leading-edge technology combined with market leading expertise and best practice processes streamline the collection and management of images during clinical trials.
As experts in medical imaging and cardiac safety testing for clinical trials, we provide the ideal combination of personal service, global reach, scientific expertise, and on-time data delivery. Our core team of more than 250 qualified clinical imaging professionals includes radiologists, imaging scientists, and certified imaging technologists. These highly trained and experienced experts will provide advice on imaging endpoints and the critical uses of imaging for the medical, scientific and regulatory aspects of your trial - enabling improved clinical trial decision making and successful outcomes.
Experts in the complex world of clinical trial oncology response criteria implementation
Experience in all cardiovascular indications and imaging modalities
Clinical trial imaging study experience across a variety of central nervous system diseases
Multi-modal image acquisition and processing expertise in NASH and obesity assessments
Collect and hold in early phase imaging clinical trials
Seamless take over and delivery of image analysis results according to your trial schedule.
Leading edge technology to streamline the collection, management and analysis of images during clinical trials.
|
|
|